Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 6
2006 4
2007 5
2008 6
2009 4
2010 5
2011 6
2012 18
2013 18
2014 8
2015 21
2016 13
2017 24
2018 27
2019 20
2020 22
2021 19
2022 23
2023 26
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

265 results

Results by year

Filters applied: . Clear all
Page 1
Engineering metal-carbide hydrogen traps in steels.
Liu PY, Zhang B, Niu R, Lu SL, Huang C, Wang M, Tian F, Mao Y, Li T, Burr PA, Lu H, Guo A, Yen HW, Cairney JM, Chen H, Chen YS. Liu PY, et al. Among authors: mao y. Nat Commun. 2024 Jan 25;15(1):724. doi: 10.1038/s41467-024-45017-4. Nat Commun. 2024. PMID: 38267467 Free PMC article.
Hydrogel Microparticles for Bone Regeneration.
Bektas C, Mao Y. Bektas C, et al. Among authors: mao y. Gels. 2023 Dec 28;10(1):28. doi: 10.3390/gels10010028. Gels. 2023. PMID: 38247752 Free PMC article. Review.
Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy.
Huang C, Guo Y, Li T, Sun G, Yang J, Wang Y, Xiang Y, Wang L, Jin M, Li J, Zhou Y, Han B, Huang R, Qiu J, Tan Y, Hu J, Wei Y, Wu B, Mao Y, Lei L, Song X, Li S, Wang Y, Zhang T. Huang C, et al. Among authors: mao y. Redox Biol. 2024 Apr;70:103024. doi: 10.1016/j.redox.2023.103024. Epub 2024 Jan 10. Redox Biol. 2024. PMID: 38232458 Free PMC article.
A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non-small-cell lung cancer who have progressed after anti-PD-1/L1 therapy.
Zhao Y, Chen X, Yao J, Long J, Mao Y, Wu D, Zang A, Zhao J, Liu Z, Meng R, Chen Y, Luo Y, Guo Q, Li L, Cui J. Zhao Y, et al. Among authors: mao y. Cancer Med. 2024 Feb;13(3):e6855. doi: 10.1002/cam4.6855. Epub 2024 Jan 12. Cancer Med. 2024. PMID: 38214075 Free PMC article. Clinical Trial.
265 results